日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out

抗癌化合物筛选发现,抑制 Aurora 激酶 A 可作为一种手段,使 CRISPR/Cas9 基因编辑优于基因敲除。

Wilbie, Danny; Eising, Selma; Amo-Addae, Vicky; Walther, Johanna; Bosman, Esmeralda; Lei, Zhiyong; de Jong, Olivier G; Molenaar, Jan J; Mastrobattista, Enrico

Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

肝母细胞瘤肿瘤和类器官中 WNT 信号传导和药物敏感性特征的差异

Kluiver Thomas A, Lu Yuyan, Schubert Stephanie A, Kraaier Lianne J, Ringnalda Femke, Lijnzaad Philip, DeMartino Jeff, Megchelenbrink Wouter L, Amo-Addae Vicky, Eising Selma, de Faria Flavia W, Münter Daniel, van de Wetering Marc, Kerl Kornelius, Duiker Evelien, van den Heuvel Marius C, de Meijer Vincent E, de Kleine Ruben H, Molenaar Jan J, Margaritis Thanasis, Stunnenberg Hendrik G, de Krijger Ronald R, Zsiros József, Clevers Hans, Peng Weng Chuan

The potential of PARP as a therapeutic target across pediatric solid malignancies

PARP作为儿童实体恶性肿瘤治疗靶点的潜力

Keller, Kaylee M; Koetsier, Joost; Schild, Linda; Amo-Addae, Vicky; Eising, Selma; van den Handel, Kim; Ober, Kimberley; Koopmans, Bianca; Essing, Anke; van den Boogaard, Marlinde L; Langenberg, Karin P S; Jäger, Natalie; Kool, Marcel; Pfister, Stefan; Dolman, M Emmy M; Molenaar, Jan J; van Hooff, Sander R